Summary
Animal model is a living, non-human animal used during the research and investigation of human disease, for the purpose of better understanding the disease without the added risk of harming an actual human being during the process.
Animal models have been used to address a variety of scientific questions, from basic science to the development and assessment of novel vaccines, or therapies. The use of animals is not only based on the vast commonalities in the biology of most mammals, but also on the fact that human diseases often affect other animal species. It is particularly the case for most infectious diseases but also for very common conditions such as Type I diabetes, hypertension, allergies, cancer, epilepsy, myopathies and so on. Not only are these diseases shared but the mechanisms are often also so similar that 90% of the veterinary drugs used to treat animals are identical or very similar to those used to treat humans.
In our report, all the animals used in scientific purposes are included.
According to APO Research, The global Animal Model for Testing market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Animal Model for Testing is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Animal Model for Testing is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Animal Model for Testing is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Animal Model for Testing is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Animal Model for Testing include Charles River Laboratories, Envigo, Taconic Biosciences, Jackson Laboratory, Crown Biosciences, Shanghai SLAC, Shangghai Modelorg, GenOway and Syngene International, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Animal Model for Testing, market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Animal Model for Testing, also provides the revenue of main regions and countries. Of the upcoming market potential for Animal Model for Testing, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Animal Model for Testing revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Animal Model for Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Animal Model for Testing revenue, projected growth trends, production technology, application and end-user industry.
Animal Model for Testing segment by Company
Charles River Laboratories
Envigo
Taconic Biosciences
Jackson Laboratory
Crown Biosciences
Shanghai SLAC
Shangghai Modelorg
GenOway
Syngene International
Psychogenics
Pharmaron
Pharmalegacy
Vitalstar Biotechnology
Animal Model for Testing segment by Type
Rats
Mice
Others
Animal Model for Testing segment by Application
Academic and Research Institutes
Pharmaceutical and Biotechnology Companies
Animal Model for Testing segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Animal Model for Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Animal Model for Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Animal Model for Testing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Animal Model for Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Animal Model for Testing company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Animal Model for Testing revenue, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
1 Market Overview
1.1 Product Definition
1.2 Animal Model for Testing Market by Type
1.2.1 Global Animal Model for Testing Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Rats
1.2.3 Mice
1.2.4 Others
1.3 Animal Model for Testing Market by Application
1.3.1 Global Animal Model for Testing Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Academic and Research Institutes
1.3.3 Pharmaceutical and Biotechnology Companies
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Animal Model for Testing Market Dynamics
2.1 Animal Model for Testing Industry Trends
2.2 Animal Model for Testing Industry Drivers
2.3 Animal Model for Testing Industry Opportunities and Challenges
2.4 Animal Model for Testing Industry Restraints
3 Global Growth Perspective
3.1 Global Animal Model for Testing Market Perspective (2019-2030)
3.2 Global Animal Model for Testing Growth Trends by Region
3.2.1 Global Animal Model for Testing Market Size by Region: 2019 VS 2023 VS 2030
3.2.2 Global Animal Model for Testing Market Size by Region (2019-2024)
3.2.3 Global Animal Model for Testing Market Size by Region (2025-2030)
4 Competitive Landscape by Players
4.1 Global Animal Model for Testing Revenue by Players
4.1.1 Global Animal Model for Testing Revenue by Players (2019-2024)
4.1.2 Global Animal Model for Testing Revenue Market Share by Players (2019-2024)
4.1.3 Global Animal Model for Testing Players Revenue Share Top 10 and Top 5 in 2023
4.2 Global Animal Model for Testing Key Players Ranking, 2022 VS 2023 VS 2024
4.3 Global Animal Model for Testing Key Players Headquarters & Area Served
4.4 Global Animal Model for Testing Players, Product Type & Application
4.5 Global Animal Model for Testing Players Commercialization Time
4.6 Market Competitive Analysis
4.6.1 Global Animal Model for Testing Market CR5 and HHI
4.6.2 Global Top 5 and 10 Animal Model for Testing Players Market Share by Revenue in 2023
4.6.3 2023 Animal Model for Testing Tier 1, Tier 2, and Tier 3
5 Animal Model for Testing Market Size by Type
5.1 Global Animal Model for Testing Revenue by Type (2019 VS 2023 VS 2030)
5.2 Global Animal Model for Testing Revenue by Type (2019-2030)
5.3 Global Animal Model for Testing Revenue Market Share by Type (2019-2030)
6 Animal Model for Testing Market Size by Application
6.1 Global Animal Model for Testing Revenue by Application (2019 VS 2023 VS 2030)
6.2 Global Animal Model for Testing Revenue by Application (2019-2030)
6.3 Global Animal Model for Testing Revenue Market Share by Application (2019-2030)
7 Company Profiles
7.1 Charles River Laboratories
7.1.1 Charles River Laboratories Comapny Information
7.1.2 Charles River Laboratories Business Overview
7.1.3 Charles River Laboratories Animal Model for Testing Revenue and Gross Margin (2019-2024)
7.1.4 Charles River Laboratories Animal Model for Testing Product Portfolio
7.1.5 Charles River Laboratories Recent Developments
7.2 Envigo
7.2.1 Envigo Comapny Information
7.2.2 Envigo Business Overview
7.2.3 Envigo Animal Model for Testing Revenue and Gross Margin (2019-2024)
7.2.4 Envigo Animal Model for Testing Product Portfolio
7.2.5 Envigo Recent Developments
7.3 Taconic Biosciences
7.3.1 Taconic Biosciences Comapny Information
7.3.2 Taconic Biosciences Business Overview
7.3.3 Taconic Biosciences Animal Model for Testing Revenue and Gross Margin (2019-2024)
7.3.4 Taconic Biosciences Animal Model for Testing Product Portfolio
7.3.5 Taconic Biosciences Recent Developments
7.4 Jackson Laboratory
7.4.1 Jackson Laboratory Comapny Information
7.4.2 Jackson Laboratory Business Overview
7.4.3 Jackson Laboratory Animal Model for Testing Revenue and Gross Margin (2019-2024)
7.4.4 Jackson Laboratory Animal Model for Testing Product Portfolio
7.4.5 Jackson Laboratory Recent Developments
7.5 Crown Biosciences
7.5.1 Crown Biosciences Comapny Information
7.5.2 Crown Biosciences Business Overview
7.5.3 Crown Biosciences Animal Model for Testing Revenue and Gross Margin (2019-2024)
7.5.4 Crown Biosciences Animal Model for Testing Product Portfolio
7.5.5 Crown Biosciences Recent Developments
7.6 Shanghai SLAC
7.6.1 Shanghai SLAC Comapny Information
7.6.2 Shanghai SLAC Business Overview
7.6.3 Shanghai SLAC Animal Model for Testing Revenue and Gross Margin (2019-2024)
7.6.4 Shanghai SLAC Animal Model for Testing Product Portfolio
7.6.5 Shanghai SLAC Recent Developments
7.7 Shangghai Modelorg
7.7.1 Shangghai Modelorg Comapny Information
7.7.2 Shangghai Modelorg Business Overview
7.7.3 Shangghai Modelorg Animal Model for Testing Revenue and Gross Margin (2019-2024)
7.7.4 Shangghai Modelorg Animal Model for Testing Product Portfolio
7.7.5 Shangghai Modelorg Recent Developments
7.8 GenOway
7.8.1 GenOway Comapny Information
7.8.2 GenOway Business Overview
7.8.3 GenOway Animal Model for Testing Revenue and Gross Margin (2019-2024)
7.8.4 GenOway Animal Model for Testing Product Portfolio
7.8.5 GenOway Recent Developments
7.9 Syngene International
7.9.1 Syngene International Comapny Information
7.9.2 Syngene International Business Overview
7.9.3 Syngene International Animal Model for Testing Revenue and Gross Margin (2019-2024)
7.9.4 Syngene International Animal Model for Testing Product Portfolio
7.9.5 Syngene International Recent Developments
7.10 Psychogenics
7.10.1 Psychogenics Comapny Information
7.10.2 Psychogenics Business Overview
7.10.3 Psychogenics Animal Model for Testing Revenue and Gross Margin (2019-2024)
7.10.4 Psychogenics Animal Model for Testing Product Portfolio
7.10.5 Psychogenics Recent Developments
7.11 Pharmaron
7.11.1 Pharmaron Comapny Information
7.11.2 Pharmaron Business Overview
7.11.3 Pharmaron Animal Model for Testing Revenue and Gross Margin (2019-2024)
7.11.4 Pharmaron Animal Model for Testing Product Portfolio
7.11.5 Pharmaron Recent Developments
7.12 Pharmalegacy
7.12.1 Pharmalegacy Comapny Information
7.12.2 Pharmalegacy Business Overview
7.12.3 Pharmalegacy Animal Model for Testing Revenue and Gross Margin (2019-2024)
7.12.4 Pharmalegacy Animal Model for Testing Product Portfolio
7.12.5 Pharmalegacy Recent Developments
7.13 Vitalstar Biotechnology
7.13.1 Vitalstar Biotechnology Comapny Information
7.13.2 Vitalstar Biotechnology Business Overview
7.13.3 Vitalstar Biotechnology Animal Model for Testing Revenue and Gross Margin (2019-2024)
7.13.4 Vitalstar Biotechnology Animal Model for Testing Product Portfolio
7.13.5 Vitalstar Biotechnology Recent Developments
8 North America
8.1 North America Animal Model for Testing Revenue (2019-2030)
8.2 North America Animal Model for Testing Revenue by Type (2019-2030)
8.2.1 North America Animal Model for Testing Revenue by Type (2019-2024)
8.2.2 North America Animal Model for Testing Revenue by Type (2025-2030)
8.3 North America Animal Model for Testing Revenue Share by Type (2019-2030)
8.4 North America Animal Model for Testing Revenue by Application (2019-2030)
8.4.1 North America Animal Model for Testing Revenue by Application (2019-2024)
8.4.2 North America Animal Model for Testing Revenue by Application (2025-2030)
8.5 North America Animal Model for Testing Revenue Share by Application (2019-2030)
8.6 North America Animal Model for Testing Revenue by Country
8.6.1 North America Animal Model for Testing Revenue by Country (2019 VS 2023 VS 2030)
8.6.2 North America Animal Model for Testing Revenue by Country (2019-2024)
8.6.3 North America Animal Model for Testing Revenue by Country (2025-2030)
8.6.4 United States
8.6.5 Canada
9 Europe
9.1 Europe Animal Model for Testing Revenue (2019-2030)
9.2 Europe Animal Model for Testing Revenue by Type (2019-2030)
9.2.1 Europe Animal Model for Testing Revenue by Type (2019-2024)
9.2.2 Europe Animal Model for Testing Revenue by Type (2025-2030)
9.3 Europe Animal Model for Testing Revenue Share by Type (2019-2030)
9.4 Europe Animal Model for Testing Revenue by Application (2019-2030)
9.4.1 Europe Animal Model for Testing Revenue by Application (2019-2024)
9.4.2 Europe Animal Model for Testing Revenue by Application (2025-2030)
9.5 Europe Animal Model for Testing Revenue Share by Application (2019-2030)
9.6 Europe Animal Model for Testing Revenue by Country
9.6.1 Europe Animal Model for Testing Revenue by Country (2019 VS 2023 VS 2030)
9.6.2 Europe Animal Model for Testing Revenue by Country (2019-2024)
9.6.3 Europe Animal Model for Testing Revenue by Country (2025-2030)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Russia
10 China
10.1 China Animal Model for Testing Revenue (2019-2030)
10.2 China Animal Model for Testing Revenue by Type (2019-2030)
10.2.1 China Animal Model for Testing Revenue by Type (2019-2024)
10.2.2 China Animal Model for Testing Revenue by Type (2025-2030)
10.3 China Animal Model for Testing Revenue Share by Type (2019-2030)
10.4 China Animal Model for Testing Revenue by Application (2019-2030)
10.4.1 China Animal Model for Testing Revenue by Application (2019-2024)
10.4.2 China Animal Model for Testing Revenue by Application (2025-2030)
10.5 China Animal Model for Testing Revenue Share by Application (2019-2030)
11 Asia (Excluding China)
11.1 Asia Animal Model for Testing Revenue (2019-2030)
11.2 Asia Animal Model for Testing Revenue by Type (2019-2030)
11.2.1 Asia Animal Model for Testing Revenue by Type (2019-2024)
11.2.2 Asia Animal Model for Testing Revenue by Type (2025-2030)
11.3 Asia Animal Model for Testing Revenue Share by Type (2019-2030)
11.4 Asia Animal Model for Testing Revenue by Application (2019-2030)
11.4.1 Asia Animal Model for Testing Revenue by Application (2019-2024)
11.4.2 Asia Animal Model for Testing Revenue by Application (2025-2030)
11.5 Asia Animal Model for Testing Revenue Share by Application (2019-2030)
11.6 Asia Animal Model for Testing Revenue by Country
11.6.1 Asia Animal Model for Testing Revenue by Country (2019 VS 2023 VS 2030)
11.6.2 Asia Animal Model for Testing Revenue by Country (2019-2024)
11.6.3 Asia Animal Model for Testing Revenue by Country (2025-2030)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 China Taiwan
11.6.9 Southeast Asia
12 Middle East, Africa, Latin America
12.1 MEALA Animal Model for Testing Revenue (2019-2030)
12.2 MEALA Animal Model for Testing Revenue by Type (2019-2030)
12.2.1 MEALA Animal Model for Testing Revenue by Type (2019-2024)
12.2.2 MEALA Animal Model for Testing Revenue by Type (2025-2030)
12.3 MEALA Animal Model for Testing Revenue Share by Type (2019-2030)
12.4 MEALA Animal Model for Testing Revenue by Application (2019-2030)
12.4.1 MEALA Animal Model for Testing Revenue by Application (2019-2024)
12.4.2 MEALA Animal Model for Testing Revenue by Application (2025-2030)
12.5 MEALA Animal Model for Testing Revenue Share by Application (2019-2030)
12.6 MEALA Animal Model for Testing Revenue by Country
12.6.1 MEALA Animal Model for Testing Revenue by Country (2019 VS 2023 VS 2030)
12.6.2 MEALA Animal Model for Testing Revenue by Country (2019-2024)
12.6.3 MEALA Animal Model for Testing Revenue by Country (2025-2030)
12.6.4 Mexico
12.6.5 Brazil
12.6.6 Israel
12.6.7 Argentina
12.6.8 Colombia
12.6.9 Turkey
12.6.10 Saudi Arabia
12.6.11 UAE
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
List of Tables
Table 1. Global Animal Model for Testing Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 1. Rats Major Manufacturers
Table 2. Mice Major Manufacturers
Table 3. Others Major Manufacturers
Table 4. Global Animal Model for Testing Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 5. Academic and Research Institutes Major Manufacturers
Table 6. Pharmaceutical and Biotechnology Companies Major Manufacturers
Table 7. Animal Model for Testing Industry Trends
Table 8. Animal Model for Testing Industry Drivers
Table 9. Animal Model for Testing Industry Opportunities and Challenges
Table 10. Animal Model for Testing Industry Restraints
Table 11. Global Animal Model for Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 12. Global Animal Model for Testing Market Size by Region (2019-2024) & (US$ Million)
Table 13. Global Animal Model for Testing Market Share by Region (2019-2024)
Table 14. Global Animal Model for Testing Market Size by Region (2025-2030) & (US$ Million)
Table 15. Global Animal Model for Testing Market Share by Region (2025-2030)
Table 16. Global Animal Model for Testing Revenue by Players (US$ Million) & (2019-2024)
Table 17. Global Animal Model for Testing Revenue Market Share by Players (2019-2024)
Table 18. Global Animal Model for Testing Key Players Ranking, 2022 VS 2023 VS 2024
Table 19. Global Animal Model for Testing Key Players Headquarters & Area Served
Table 20. Global Animal Model for Testing Players, Product Type & Application
Table 21. Global Animal Model for Testing Players Commercialization Time
Table 22. Global Players Market Concentration Ratio (CR5 and HHI)
Table 23. Global Animal Model for Testing by Players Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 24. Global Animal Model for Testing Revenue by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 25. Global Animal Model for Testing Revenue by Type (2019-2024) & (US$ Million)
Table 26. Global Animal Model for Testing Revenue by Type (2025-2030) & (US$ Million)
Table 27. Global Animal Model for Testing Revenue Market Share by Type (2019-2024) & (US$ Million)
Table 28. Global Animal Model for Testing Revenue Market Share by Type (2025-2030) & (US$ Million)
Table 29. Global Animal Model for Testing Revenue by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 30. Global Animal Model for Testing Revenue by Application (2019-2024) & (US$ Million)
Table 31. Global Animal Model for Testing Revenue by Application (2025-2030) & (US$ Million)
Table 32. Global Animal Model for Testing Revenue Market Share by Application (2019-2024) & (US$ Million)
Table 33. Global Animal Model for Testing Revenue Market Share by Application (2025-2030) & (US$ Million)
Table 34. Charles River Laboratories Company Information
Table 35. Charles River Laboratories Business Overview
Table 36. Charles River Laboratories Animal Model for Testing Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 37. Charles River Laboratories Animal Model for Testing Product Portfolio
Table 38. Charles River Laboratories Recent Development
Table 39. Envigo Company Information
Table 40. Envigo Business Overview
Table 41. Envigo Animal Model for Testing Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 42. Envigo Animal Model for Testing Product Portfolio
Table 43. Envigo Recent Development
Table 44. Taconic Biosciences Company Information
Table 45. Taconic Biosciences Business Overview
Table 46. Taconic Biosciences Animal Model for Testing Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 47. Taconic Biosciences Animal Model for Testing Product Portfolio
Table 48. Taconic Biosciences Recent Development
Table 49. Jackson Laboratory Company Information
Table 50. Jackson Laboratory Business Overview
Table 51. Jackson Laboratory Animal Model for Testing Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 52. Jackson Laboratory Animal Model for Testing Product Portfolio
Table 53. Jackson Laboratory Recent Development
Table 54. Crown Biosciences Company Information
Table 55. Crown Biosciences Business Overview
Table 56. Crown Biosciences Animal Model for Testing Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 57. Crown Biosciences Animal Model for Testing Product Portfolio
Table 58. Crown Biosciences Recent Development
Table 59. Shanghai SLAC Company Information
Table 60. Shanghai SLAC Business Overview
Table 61. Shanghai SLAC Animal Model for Testing Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 62. Shanghai SLAC Animal Model for Testing Product Portfolio
Table 63. Shanghai SLAC Recent Development
Table 64. Shangghai Modelorg Company Information
Table 65. Shangghai Modelorg Business Overview
Table 66. Shangghai Modelorg Animal Model for Testing Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 67. Shangghai Modelorg Animal Model for Testing Product Portfolio
Table 68. Shangghai Modelorg Recent Development
Table 69. GenOway Company Information
Table 70. GenOway Business Overview
Table 71. GenOway Animal Model for Testing Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 72. GenOway Animal Model for Testing Product Portfolio
Table 73. GenOway Recent Development
Table 74. Syngene International Company Information
Table 75. Syngene International Business Overview
Table 76. Syngene International Animal Model for Testing Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 77. Syngene International Animal Model for Testing Product Portfolio
Table 78. Syngene International Recent Development
Table 79. Psychogenics Company Information
Table 80. Psychogenics Business Overview
Table 81. Psychogenics Animal Model for Testing Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 82. Psychogenics Animal Model for Testing Product Portfolio
Table 83. Psychogenics Recent Development
Table 84. Pharmaron Company Information
Table 85. Pharmaron Business Overview
Table 86. Pharmaron Animal Model for Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 87. Pharmaron Animal Model for Testing Product Portfolio
Table 88. Pharmaron Recent Development
Table 89. Pharmalegacy Company Information
Table 90. Pharmalegacy Business Overview
Table 91. Pharmalegacy Animal Model for Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 92. Pharmalegacy Animal Model for Testing Product Portfolio
Table 93. Pharmalegacy Recent Development
Table 94. Vitalstar Biotechnology Company Information
Table 95. Vitalstar Biotechnology Business Overview
Table 96. Vitalstar Biotechnology Animal Model for Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 97. Vitalstar Biotechnology Animal Model for Testing Product Portfolio
Table 98. Vitalstar Biotechnology Recent Development
Table 99. North America Animal Model for Testing Revenue by Type (2019-2024) & (US$ Million)
Table 100. North America Animal Model for Testing Revenue by Application (2019-2024) & (US$ Million)
Table 101. North America Animal Model for Testing Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 102. North America Animal Model for Testing Revenue by Country (2019-2024) & (US$ Million)
Table 103. North America Animal Model for Testing Revenue by Country (2025-2030) & (US$ Million)
Table 104. Europe Animal Model for Testing Revenue by Type (2019-2024) & (US$ Million)
Table 105. Europe Animal Model for Testing Revenue by Application (2019-2024) & (US$ Million)
Table 106. Europe Animal Model for Testing Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 107. Europe Animal Model for Testing Revenue by Country (2019-2024) & (US$ Million)
Table 108. Europe Animal Model for Testing Revenue by Country (2025-2030) & (US$ Million)
Table 109. China Animal Model for Testing Revenue by Type (2019-2024) & (US$ Million)
Table 110. China Animal Model for Testing Revenue by Application (2019-2024) & (US$ Million)
Table 111. Asia Animal Model for Testing Revenue by Type (2019-2024) & (US$ Million)
Table 112. Asia Animal Model for Testing Revenue by Application (2019-2024) & (US$ Million)
Table 113. Asia Animal Model for Testing Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 114. Asia Animal Model for Testing Revenue by Country (2019-2024) & (US$ Million)
Table 115. Asia Animal Model for Testing Revenue by Country (2025-2030) & (US$ Million)
Table 116. MEALA Animal Model for Testing Revenue by Type (2019-2024) & (US$ Million)
Table 117. MEALA Animal Model for Testing Revenue by Application (2019-2024) & (US$ Million)
Table 118. MEALA Animal Model for Testing Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 119. MEALA Animal Model for Testing Revenue by Country (2019-2024) & (US$ Million)
Table 120. MEALA Animal Model for Testing Revenue by Country (2025-2030) & (US$ Million)
Table 121. Research Programs/Design for This Report
Table 122. Authors List of This Report
Table 123. Secondary Sources
Table 124. Primary Sources
List of Figures
Figure 1. Animal Model for Testing Product Picture
Figure 2. Global Animal Model for Testing Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Animal Model for Testing Market Size Share 2019 VS 2023 VS 2030
Figure 4. Rats Picture
Figure 5. Mice Picture
Figure 6. Others Picture
Figure 7. Global Animal Model for Testing Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Figure 8. Global Animal Model for Testing Market Size Share 2019 VS 2023 VS 2030
Figure 9. Academic and Research Institutes Picture
Figure 10. Pharmaceutical and Biotechnology Companies Picture
Figure 11. Global Animal Model for Testing Market Size (US$ Million) & (2019-2030)
Figure 12. Global Animal Model for Testing Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Animal Model for Testing Market Share by Region: 2019 VS 2023 VS 2030
Figure 14. Global Animal Model for Testing Players Revenue Share Top 10 and Top 5 in 2023
Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 16. Global Animal Model for Testing Revenue by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 17. Global Animal Model for Testing Revenue Market Share 2019 VS 2023 VS 2030
Figure 18. Global Animal Model for Testing Revenue Market Share by Type (2019-2030)
Figure 19. Global Animal Model for Testing Revenue by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 20. Global Animal Model for Testing Revenue Market Share by Application (2019 VS 2023 VS 2030)
Figure 21. Global Animal Model for Testing Revenue Market Share by Application (2019-2030)
Figure 22. North America Animal Model for Testing Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 23. North America Animal Model for Testing Revenue by Type (2025-2030) & (US$ Million)
Figure 24. North America Animal Model for Testing Revenue Share by Type (2019-2030)
Figure 25. North America Animal Model for Testing Revenue by Application (2025-2030) & (US$ Million)
Figure 26. North America Animal Model for Testing Revenue Share by Application (2019-2030)
Figure 27. North America Animal Model for Testing Revenue Share by Country (2019-2030)
Figure 28. United States Animal Model for Testing Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 29. Canada Animal Model for Testing Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 30. Europe Animal Model for Testing Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 31. Europe Animal Model for Testing Revenue by Type (2025-2030) & (US$ Million)
Figure 32. Europe Animal Model for Testing Revenue Share by Type (2019-2030)
Figure 33. Europe Animal Model for Testing Revenue by Application (2025-2030) & (US$ Million)
Figure 34. Europe Animal Model for Testing Revenue Share by Application (2019-2030)
Figure 35. Europe Animal Model for Testing Revenue Share by Country (2019-2030)
Figure 36. Germany Animal Model for Testing Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 37. France Animal Model for Testing Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 38. U.K. Animal Model for Testing Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 39. Italy Animal Model for Testing Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 40. Russia Animal Model for Testing Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 41. Nordic Countries Animal Model for Testing Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 42. China Animal Model for Testing Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 43. China Animal Model for Testing Revenue by Type (2025-2030) & (US$ Million)
Figure 44. China Animal Model for Testing Revenue Share by Type (2019-2030)
Figure 45. China Animal Model for Testing Revenue by Application (2025-2030) & (US$ Million)
Figure 46. China Animal Model for Testing Revenue Share by Application (2019-2030)
Figure 47. Asia Animal Model for Testing Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 48. Asia Animal Model for Testing Revenue by Type (2025-2030) & (US$ Million)
Figure 49. Asia Animal Model for Testing Revenue Share by Type (2019-2030)
Figure 50. Asia Animal Model for Testing Revenue by Application (2025-2030) & (US$ Million)
Figure 51. Asia Animal Model for Testing Revenue Share by Application (2019-2030)
Figure 52. Asia Animal Model for Testing Revenue Share by Country (2019-2030)
Figure 53. Japan Animal Model for Testing Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 54. South Korea Animal Model for Testing Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 55. India Animal Model for Testing Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 56. Australia Animal Model for Testing Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 57. China Taiwan Animal Model for Testing Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 58. Southeast Asia Animal Model for Testing Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 59. MEALA Animal Model for Testing Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 60. MEALA Animal Model for Testing Revenue by Type (2025-2030) & (US$ Million)
Figure 61. MEALA Animal Model for Testing Revenue Share by Type (2019-2030)
Figure 62. MEALA Animal Model for Testing Revenue by Application (2025-2030) & (US$ Million)
Figure 63. MEALA Animal Model for Testing Revenue Share by Application (2019-2030)
Figure 64. MEALA Animal Model for Testing Revenue Share by Country (2019-2030)
Figure 65. Mexico Animal Model for Testing Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 66. South Korea Animal Model for Testing Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 67. Brazil Animal Model for Testing Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 68. Israel Animal Model for Testing Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 69. Argentina Animal Model for Testing Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 70. Colombia Animal Model for Testing Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 71. Turkey Animal Model for Testing Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 72. Saudi Arabia Animal Model for Testing Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 73. UAE Animal Model for Testing Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 74. Years Considered
Figure 75. Research Process
Figure 76. Key Executives Interviewed
